.Bristol Myers Squibb has possessed a whiplash change of mind on its BCMA bispecific T-cell engager,...
.Charles Baum, M.D., Ph.D., who managed Mirati Therapies' $ 5.8 billion sale to Bristol Myers Squibb...
.After communicating to more than 200 firms to companion a Tourette syndrome therapy that showed the...
.Novartis has actually possessed some misfortune with bispecific antibodies previously, however eval...
.Pinetree Therapies will help AstraZeneca vegetation some trees in its own pipe with a new pact to e...
.GRO Biosciences has actually ended the week with an extra $60.3 thousand in the bank, which the pro...
.Accept to today's Chutes & Ladders, our roundup of notable management hirings, firings and retir...